Noto N, Ayusawa M, Karasawa K, Yamaguchi H, Sumitomo N, Okada T, Harada K
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
J Am Coll Cardiol. 1996 Apr;27(5):1251-6. doi: 10.1016/0735-1097(95)00570-6.
This study was designed to assess the feasibility and diagnostic accuracy of dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease.
Dobutamine stress echocardiography is valuable as an alternative test for detection of coronary artery disease in adult patients; however, its usefulness for children has been demonstrated only in limited cases.
Dobutamine stress echocardiography (up to 30 microgram/kg body weight per min) was performed in 50 patients at the convalescent stage of Kawasaki disease, including 26 patients with coronary sequelae documented by previous coronary angiography (sequelae group, 3 to 15 years old) and 24 patients with normal coronary arteries documented by echocardiography (normal group, 7 to 16 years old), who underwent quantitative coronary angiography on a separate day. Left ventricular regional wall motion divided into 16 segments was assessed in relation to the extent of coronary artery disease. A positive test response was defined as a new or worsened wall motion abnormalities.
Significant coronary artery disease (> or = 50% diameter stenosis of major vessels) was present in 21 patients in the sequelae group. There was no significant difference in the maximal dose of dobutamine between the sequelae and normal groups ([mean +/- SD] 22.4 +/- 5.1 vs. 24.2 +/- 2.5 microgram/kg per min). Heart rate and systolic blood pressure were significantly increased (p < 0.01) at maximal dose of dobutamine compared with values at rest in both groups; consequently, the rate-pressure product exceeded 20,000 in 20 (40%) of the 50 patients during dobutamine infusion. Ten patients had self-limiting side effects; however, there were no serious complications from stress-induced ischemia. New wall motion abnormalities corresponding to the extent of coronary artery disease were detected in 19 of 21 patients in the sequelae group, whereas no wall motion abnormalities were detected in the normal group. Thus, the sensitivity and specificity of dobutamine stress echocardiography for the detection of coronary artery disease were 90% and 100%, respectively.
We conclude that dobutamine stress echocardiography is a safe and accurate diagnostic method for detection of coronary artery stenosis in Kawasaki disease. Moreover, this is a possible alternative method for patients unable to exercise adequately, even if they are small children.
本研究旨在评估多巴酚丁胺负荷超声心动图检测川崎病患儿冠状动脉狭窄的可行性及诊断准确性。
多巴酚丁胺负荷超声心动图作为检测成年患者冠状动脉疾病的替代检查方法具有重要价值;然而,其在儿童中的应用仅在有限的病例中得到证实。
对50例处于川崎病恢复期的患者进行多巴酚丁胺负荷超声心动图检查(最大剂量达每分钟30微克/千克体重),其中包括26例先前冠状动脉造影证实有冠状动脉后遗症的患者(后遗症组,3至15岁)和24例超声心动图证实冠状动脉正常的患者(正常组,7至16岁),这些患者在另一天接受了定量冠状动脉造影。根据冠状动脉疾病的程度评估分为16个节段的左心室节段性室壁运动。阳性试验反应定义为新出现或加重的室壁运动异常。
后遗症组21例患者存在显著冠状动脉疾病(主要血管直径狭窄≥50%)。后遗症组与正常组之间多巴酚丁胺的最大剂量无显著差异([均值±标准差]分别为22.⁴±5.¹与24.²±2.⁵微克/千克每分钟)。与静息值相比,两组在多巴酚丁胺最大剂量时心率和收缩压均显著升高(p<0.01);因此,在50例患者中,有20例(40%)在多巴酚丁胺输注期间心率 - 血压乘积超过20,000。10例患者出现自限性副作用;然而,应激诱导的缺血未导致严重并发症。后遗症组21例患者中有19例检测到与冠状动脉疾病程度相对应的新的室壁运动异常,而正常组未检测到室壁运动异常。因此,多巴酚丁胺负荷超声心动图检测冠状动脉疾病的敏感性和特异性分别为90%和100%。
我们得出结论,多巴酚丁胺负荷超声心动图是检测川崎病冠状动脉狭窄的一种安全、准确的诊断方法。此外,即使对于幼儿,这也是一种适用于无法充分运动患者的可能替代方法。